BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/11/2025 8:20:57 AM | Browse: 184 | Download: 689
 |
Received |
|
2025-08-08 05:59 |
|
Peer-Review Started |
|
2025-08-08 05:59 |
|
First Decision by Editorial Office Director |
|
2025-08-22 08:34 |
|
Return for Revision |
|
2025-08-22 08:34 |
|
Revised |
|
2025-09-05 02:27 |
|
Publication Fee Transferred |
|
2025-09-08 06:31 |
|
Second Decision by Editor |
|
2025-10-20 02:45 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-20 07:10 |
|
Articles in Press |
|
2025-10-20 07:10 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-26 09:36 |
|
Publish the Manuscript Online |
|
2025-12-11 08:20 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Long-term survival after treatment of gastric cancer with S-1 plus oxaliplatin regimen and sintilimab: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jun Pan, Ping Li, Yu-He Zhou, Ting-Ting Pan, Yi-Tian Chen and Xiao-Yuan Chu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xiao-Yuan Chu, MD, Department of Oncology, Jinling Hospital, Medical School of Nanjing University, No. 305 Zhongshan East Road, Nanjing 210002, Jiangsu Province, China. chuxiaoyuan0@163.com |
| Key Words |
Metastatic gastric cancer; Sintilimab; Immunotherapy; Chemotherapy; Progression-free survival; Case report |
| Core Tip |
Chemotherapy combined with immunotherapy is the standard first-line treatment for metastatic gastric cancer. However, the first-line median progression-free survival is only about 7 months. This article reports a case of metastatic gastric cancer in which the patient received S-1 plus oxaliplatin regimen with sintilimab, followed by maintenance therapy with S-1 and sintilimab. The patient achieved a partial response and a progression-free survival of 23 months. Moreover, the treatment was temporarily paused for 6 months due to pneumonia. However, upon re-evaluation 6 months later, the tumor continued to regress. This combination therapy has shown encouraging results and warrants further study. |
| Publish Date |
2025-12-11 08:20 |
| Citation |
Pan J, Li P, Zhou YH, Pan TT, Chen YT, Chu XY. Long-term survival after treatment of gastric cancer with S-1 plus oxaliplatin regimen and sintilimab: A case report. World J Gastrointest Oncol 2025; 17(12): 112853
|
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i12/112853.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i12.112853 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
